Clinical Trials | Global Biodefense

Menu

Latest stories

Why Ebola Vaccine on Trial in DRC is Raising Hopes

Medical Device Incubator

M2D2 Support and Seed Funding Available for Medical-Device Entrepreneurs

More on pathogens and preparedness

Innovations in Regulatory Science Summit

by Global Biodefense January 5, 2019, 8:00 am
Countermeasure Development: First Ever FDA Qualification of Clinical Safety Biomarker

by Global Biodefense October 29, 2018, 9:33 am
Soligenix’s Innate Defense Regulator Selected for NIH Commercialization Transition Funding
First Human Trial of Live, Attenuated Zika Vaccine Begins

by Global Biodefense August 16, 2018, 10:36 am
MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments

by Global Biodefense May 18, 2018, 6:28 pm
Experimental MERS Antibody Therapeutics Enter Clinical Trial

by Global Biodefense May 18, 2018, 7:33 am
USAMRIID Awards Select Agent Research Reagents Contract
NIAID Virology Quality Assurance Program

by Stephanie Lizotte April 29, 2018, 1:03 pm

Back to Top

Close

close